Evidence map›Paper›PMID 36499736›Full record

ArticleInternational journal of molecular sciences2022

Dan Mihai Furcea, Laurențiu Agrigoroaie, Cosmin-T Mihai, Ioannis Gardikiotis, Gianina Dodi, Gabriela D Stanciu, Carmen Solcan, Sorin I Beschea Chiriac, Mihai Marius Guțu, Cipriana Ștefănescu

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Unravelling the pathogenesis and therapeutic approaches of pancreatic ductal adenocarcinoma.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Dan Mihai FurceaDepartment of Nuclear Medicine, Sf. Spiridon University Emergency Hospital, 700111 Iasi, Romania.
Laurențiu AgrigoroaieDepartment of Nuclear Medicine, Sf. Spiridon University Emergency Hospital, 700111 Iasi, Romania.
Cosmin-T MihaiAdvanced Research and Development Center for Experimental Medicine, Grigore T. Popa University of Medicine and Pharmacy of Iasi, 700454 Iasi, Romania.ORCID 0000-0002-0945-5437
Ioannis GardikiotisAdvanced Research and Development Center for Experimental Medicine, Grigore T. Popa University of Medicine and Pharmacy of Iasi, 700454 Iasi, Romania.ORCID 0000-0001-6071-7618
Gianina DodiAdvanced Research and Development Center for Experimental Medicine, Grigore T. Popa University of Medicine and Pharmacy of Iasi, 700454 Iasi, Romania.ORCID 0000-0002-5551-6077
Gabriela D StanciuAdvanced Research and Development Center for Experimental Medicine, Grigore T. Popa University of Medicine and Pharmacy of Iasi, 700454 Iasi, Romania.ORCID 0000-0003-4440-9628
Carmen SolcanFaculty of Veterinary Medicine, Ion Ionescu de la Brad University of Agricultural Sciences and Veterinary Medicine, 700490 Iasi, Romania.ORCID 0000-0002-0323-0296
Sorin I Beschea ChiriacFaculty of Veterinary Medicine, Ion Ionescu de la Brad University of Agricultural Sciences and Veterinary Medicine, 700490 Iasi, Romania.
Mihai Marius GuțuDepartment of Biophysics and Medical Physics-Nuclear Medicine, Grigore T. Popa University of Medicine and Pharmacy of Iasi, 700115 Iasi, Romania.ORCID 0000-0002-0763-0449
Cipriana ȘtefănescuDepartment of Biophysics and Medical Physics-Nuclear Medicine, Grigore T. Popa University of Medicine and Pharmacy of Iasi, 700115 Iasi, Romania.
Grigore T. Popa University of Medicine and Pharmacy · RO"Ion Ionescu de la Brad" Iasi University of Life Sciences · RO

Funding

Grigore T. Popa University of Medicine and Pharmacy of Iasi 30337/28.12.2017
6 · The paper itself

Abstract

Cardiorenal syndrome (CRS) denotes the bidirectional interaction of chronic kidney disease and heart failure with an adverse prognosis but with a limited understanding of its pathogenesis. This study correlates biochemical blood markers, histopathological and immunohistochemistry features, and 2-deoxy-2-fluoro-D-glucose positron emission tomography (

Indexed as

Cardio-Renal SyndromeHeart FailureAnimalsDoxorubicinFluorodeoxyglucose F18Magnetic Resonance ImagingMalePositron-Emission TomographyRatsRats, WistarDoxorubicinFluorodeoxyglucose F18animalscardiorenal syndromehistopathologyimmunohistochemistryMRIPET

Identifiers

PMID36499736
PMCPMC9738874
OpenAlexW4311674791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.